Showing results (461-470 of 529) with videos related to

Sort By:
Pageof 53
Movement Disorders : Official Journal of the Movement Disorder Society|March 8, 2025
Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine ReviewRob M A de Bie, Regina Katzenschlager, Bart E K S Swinnen, et al.
Journal of Advanced Research|May 27, 2025
Fibrinogen exacerbates α-synuclein aggregation and mitochondrial dysfunction via alpha5beta3 integrin in Parkinson's diseaseZifeng Huang, Jialing Zheng, Feilan Yuan, et al.
Parkinsonism & Related Disorders|February 21, 2021
Clinically relevant copy-number variants in exome sequencing data of patients with dystoniaMichael Zech, Sylvia Boesch, Matej Škorvánek, et al.
Journal of Parkinson'S Disease|January 24, 2022
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's DiseaseJennifer Michels, Hendrik van der Wurp, Elke Kalbe, et al.
American Journal of Human Genetics|July 19, 2011
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson diseaseAlexander Zimprich, Anna Benet-Pagès, Walter Struhal, et al.
The Lancet. Neurology|April 14, 2023
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional studyAndrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, et al.
Translational Neurodegeneration|April 16, 2019
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptorsFranziska Hopfner, Stefanie H Müller, Dagmar Steppat, et al.
The Lancet. Neurology|January 24, 2024
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for researchTanya Simuni, Lana M Chahine, Kathleen Poston, et al.
NPJ Parkinson'S Disease|September 27, 2024
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsTien Dam, Gennaro Pagano, Michael C Brumm, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohortsTien Dam, Gennaro Pagano, Michael C Brumm, et al.
Pageof 53